Walmart agrees to pay $5.6 million to settle a California lawsuit over claims of overcharging and false pricing.

An explosion at a Pennsylvania U.S. Steel plant kills 2 and injures 10, prompting safety and environmental concerns.

Brazil's planned tariff talks with the US were canceled, leaving the country seeking new trade solutions amid rising tensions.

Ford plans a $5 billion EV investment to launch an affordable $30K electric truck by 2027 with a new innovative assembly line.

Tesla confirms plans to mass-produce a cheaper Model Y amid falling sales and rising EV competition.

Claire's files for bankruptcy again, plans to close over 1,100 stores unless a buyer is found for 800 locations.

Local restaurants are struggling to survive as rising food and labor costs meet slowing customer traffic.

FTC fines Assurance IQ and MediaAlpha $145 million for misleading health insurance shoppers and illegal robocalls.

Trump criticizes $3.1B Fed building renovation, pledges to clean up crime and waste in Washington, D.C.

Limited options, high costs, and a lack of novel ideas have long hindered the treatment of rare genetic disorders. Existing therapies may manage symptoms for millions of patients worldwide, but often fall short regarding long-lasting changes. Lingyi Biotech is a clinical-stage biotechnology company that's taking a different approach.